AI to improve treatments for people with multiple long-term conditions
The NIHR has awarded £2.5 million for new artificial intelligence (AI) research led by the University of Birmingham. The study will use AI to produce computer programmes and tools to help doctors imp…
AI identifies patients with heart failure that respond to beta-blocker treatment
Researchers at BHP founder-member the University of Birmingham have developed a new way to identify which patients with heart failure will benefit from treatment with beta-blockers.
Heart failure…
Birmingham Health Partners plays key role in report calling for Government reform of regulation of medical devices
Experts within Birmingham Health Partners (BHP) have significantly contributed to a new independent report calling on the UK Government to reform the regulation of medical devices.
Lessons learned…
New Birmingham-Roche collaboration targets new treatments for inflammatory bowel disease
A new £850k collaboration between Birmingham Health Partners (BHP) and global biotechnology leaders Roche is set to improve both diagnosis and care of patients with inflammatory bowel disease (IBD) b…
World-first trial to assess ‘life-extending’ cannabis-based drug for thousands with aggressive brain tumours
BHP founder member the University of Birmingham will co-ordinate a major UK trial to analyse the efficacy of cannabis-based drug Sativex in treating the most aggressive form of brain tumours.
The ne…
Rheumatology Research Group awarded five year EULAR Centre of Excellence Status
The Rheumatology Research Group (RRG) at BHP founder-member the University of Birmingham has been awarded five-year EULAR Centre of Excellence status for the second time in a row.
EULAR (European Le…